Skip to content

Discontinued — last reported Q4 '19

Gross Profit at other companies

Merck & Co. logo
Merck & Co.MRK
$12.09B-0.2%
Amgen logo
AmgenAMGN
$5.87B+13.4%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$8.07B-1.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
Incyte logo
IncyteINCY
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.6%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.1%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$63.73B+17.8%
Enterprise value$63.47B+18.1%
P/E14.4×+2.4×
P/S4.3×+0.4×

Profitability

See full
Gross margin93.9%
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Where this comes from

Calculated from Regeneron Pharmaceuticals’s reported figures.

The official record: Regeneron Pharmaceuticals’s 10-K, filed February 7, 2022, on SEC EDGAR. View the filing →

Questions, answered.

What does gross profit mean?
The total revenue remaining after subtracting the direct costs of producing and selling the company's pharmaceutical products.
How do you interpret gross profit?
An increase suggests improved manufacturing efficiencies, favorable product mix shifts toward higher-margin therapies, or increased pricing power. A decrease may signal rising production costs, supply chain disruptions, or a shift in sales toward lower-margin products.
How does gross profit compare across companies?
In the biopharmaceutical industry, gross margins are typically high due to the value of intellectual property, though they vary based on the proportion of revenue derived from proprietary products versus partnered or generic-equivalent assets.